Digital Health Assistant & Symptom Checker | Symptoma
0%
Restart

Are you sure you want to clear all symptoms and restart the conversation?

About COVID-19 Jobs Press Terms Privacy Imprint Medical Device Language
Languages
Suggested Languages
English (English) en
Other languages 0
2.1
Panuveitis
Total Uveitis

Panuveitis is a type of uveitis, which refers to inflammation of the uvea, the middle layer of the eye. Unlike other forms of uveitis that affect specific parts of the uvea, panuveitis involves inflammation of all parts of the uvea, including the iris, ciliary body, and choroid. This condition can lead to vision problems and, if untreated, may result in vision loss.

Presentation

Patients with panuveitis often present with a range of symptoms that can affect one or both eyes. Common symptoms include redness, pain, blurred vision, light sensitivity (photophobia), and floaters (small shapes that appear to float in the field of vision). The severity of symptoms can vary, and they may develop suddenly or gradually. In some cases, panuveitis can be associated with systemic diseases, meaning it may occur alongside other health conditions affecting the body.

Workup

Diagnosing panuveitis involves a thorough eye examination by an ophthalmologist. This typically includes a slit-lamp examination to assess the front part of the eye and a dilated fundus examination to view the back of the eye. Additional tests may include optical coherence tomography (OCT) to get detailed images of the retina, and fluorescein angiography to evaluate blood flow in the retina and choroid. Blood tests and imaging studies may also be conducted to identify any underlying systemic conditions contributing to the inflammation.

Treatment

The treatment of panuveitis aims to reduce inflammation, alleviate symptoms, and prevent complications. Corticosteroids are commonly used to control inflammation and can be administered as eye drops, oral medications, or injections. In cases where corticosteroids are insufficient or cause significant side effects, immunosuppressive drugs may be prescribed. Treatment plans are often tailored to the individual, considering the severity of the condition and any underlying systemic diseases.

Prognosis

The prognosis for panuveitis varies depending on the underlying cause, the severity of the inflammation, and the timeliness of treatment. With appropriate management, many patients can achieve good control of inflammation and maintain their vision. However, chronic or recurrent panuveitis can lead to complications such as cataracts, glaucoma, or retinal damage, which may affect vision. Regular follow-up with an eye specialist is crucial to monitor the condition and adjust treatment as needed.

Etiology

Panuveitis can be caused by a variety of factors, including infections, autoimmune diseases, and trauma. Infectious causes may include viruses, bacteria, fungi, or parasites. Autoimmune conditions, where the body's immune system mistakenly attacks its own tissues, are also common causes. Examples include sarcoidosis, Behçet's disease, and Vogt-Koyanagi-Harada disease. In some cases, the exact cause of panuveitis remains unknown, and it is classified as idiopathic.

Epidemiology

Panuveitis is a relatively rare condition, accounting for a small percentage of all uveitis cases. It can affect individuals of any age, but certain causes may be more prevalent in specific age groups or populations. For instance, autoimmune-related panuveitis may be more common in young to middle-aged adults. The incidence and prevalence of panuveitis can also vary geographically, influenced by the distribution of infectious agents and genetic factors.

Pathophysiology

The pathophysiology of panuveitis involves an inflammatory response within the uvea, which can disrupt normal eye function. In autoimmune-related panuveitis, the immune system targets the uveal tissue, leading to inflammation. This inflammation can cause swelling, tissue damage, and the release of inflammatory mediators, which contribute to the symptoms experienced by patients. Understanding the underlying mechanisms is crucial for developing effective treatments and managing the condition.

Prevention

Preventing panuveitis involves managing risk factors and underlying conditions that may trigger inflammation. For individuals with known autoimmune diseases, maintaining regular medical follow-ups and adhering to prescribed treatments can help reduce the risk of eye involvement. In cases where infections are a potential cause, prompt treatment of the infection can prevent the development of panuveitis. While not all cases can be prevented, early detection and management are key to minimizing complications.

Summary

Panuveitis is a complex inflammatory condition affecting all parts of the uvea in the eye. It presents with symptoms such as redness, pain, and vision changes, and can be associated with systemic diseases. Diagnosis involves a comprehensive eye examination and may include additional tests to identify underlying causes. Treatment focuses on reducing inflammation and preventing complications, with a good prognosis achievable with timely and appropriate management. Understanding the etiology and pathophysiology aids in tailoring treatment and prevention strategies.

Patient Information

If you have been diagnosed with panuveitis, it's important to follow your eye specialist's recommendations closely. Treatment may involve medications to reduce inflammation and regular eye examinations to monitor your condition. Be aware of symptoms such as increased eye pain, redness, or changes in vision, and report these to your doctor promptly. Managing any underlying health conditions and attending regular follow-ups can help maintain your eye health and prevent complications.

Languages
Suggested Languages
English (English) en
Other languages 0
Sitemap: 1-200 201-500 -1k -2k -3k -4k -5k -6k -7k -8k -9k -10k -15k -20k -30k -50k 2.1
About Symptoma.ie COVID-19 Jobs Press
Contact Terms Privacy Imprint Medical Device